Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) saw a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 46,800 shares, a drop of 53.3% from the October 31st total of 100,200 shares. Currently, 7.5% of the shares of the company are short sold. Based on an average daily volume of 504,700 shares, the short-interest ratio is currently 0.1 days.
Analyst Upgrades and Downgrades
Separately, LADENBURG THALM/SH SH began coverage on shares of Autonomix Medical in a report on Tuesday, September 3rd. They issued a “buy” rating and a $28.00 target price for the company.
Read Our Latest Stock Analysis on Autonomix Medical
Autonomix Medical Stock Down 8.5 %
About Autonomix Medical
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Recommended Stories
- Five stocks we like better than Autonomix Medical
- Technology Stocks Explained: Here’s What to Know About Tech
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Bank Stocks – Best Bank Stocks to Invest In
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.